Japanese translation of:  A plain language summary of the CheckMate 649 study: nivolumab in combination with chemotherapy compared to chemotherapy alone for untreated advanced or metastatic cancer of the stomach or esophagus

Janjigian, Yelena Y.; Shitara, Kohei; Moehler, Markus; Garrido, Marcelo; Salman, Pamela; Wyrwicz, Lucjan; Yamaguchi, Kensei; Skoczylas, Tomasz; Campos Bragagnoli, Arinilda; Liu, Tianshu; Schenker, Michael; Yanez, Patricio; Tehfe, Mustapha; Kowalyszyn, Ruben; Karamouzis, Michalis V.; Bruges, Ricardo; Zander, Thomas; Pazo-Cid, Roberto; Hitre, Erika; Feeney, Kynan; Cleary, James M.; Poulart, Valerie; Cullen, Dana; Lei, MIng; Xiao, Hong; Kondo, Kaoru; Li, Mingshun; Ajani, Jaffer A

doi:10.25402/FON.23545860.v1

PPLS_CM649_Future Oncology 2023 (Japanese translation).pdf (13.52 MB)

Japanese translation of: A plain language summary of the CheckMate 649 study: nivolumab in combination with chemotherapy compared to chemotherapy alone for untreated advanced or metastatic cancer of the stomach or esophagus

journal contribution

posted on 2023-06-20, 14:09 authored by Yelena Y. Janjigian, Kohei Shitara, Markus Moehler, Marcelo Garrido, Pamela Salman, Lucjan Wyrwicz, Kensei Yamaguchi, Tomasz Skoczylas, Arinilda Campos Bragagnoli, Tianshu Liu, Michael Schenker, Patricio Yanez, Mustapha Tehfe, Ruben Kowalyszyn, Michalis V. Karamouzis, Ricardo Bruges, Thomas Zander, Roberto Pazo-Cid, Erika Hitre, Kynan Feeney, James M. Cleary, Valerie Poulart, Dana Cullen, MIng Lei, Hong Xiao, Kaoru Kondo, Mingshun Li, Jaffer A Ajani

Japanese Translation

History

Usage metrics

Keywords

plain language summary nivolumab lay summary immunotherapy immune checkpoint inhibitor gastroesophageal junction cancer gastric cancer esophageal cancer chemotherapy adenocarcinoma

Licence

CC BY-NC-ND 4.0

Japanese translation of: A plain language summary of the CheckMate 649 study: nivolumab in combination with chemotherapy compared to chemotherapy alone for untreated advanced or metastatic cancer of the stomach or esophagus

History

Usage metrics

Categories

Keywords

Licence

Exports